Moreover, the frequency of CD39+CD8+ TILs was higher in epidermal growth factor receptor (EGFR)-mutated lung cancers, a subgroup of patients showing low CD8+ T-cell densities and relatively poor responses to ICB. Here, CD8A is linked to lung cancer.